ELEJURN Trademark

Trademark Overview

On Monday, March 9, 2015, a trademark application was filed for ELEJURN with the United States Patent and Trademark Office. The USPTO has given the ELEJURN trademark a serial number of 86558371. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 1, 2025. This trademark is owned by Gilead Sciences Ireland UC. The ELEJURN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of HIV infection and hepatitis; antivirals; anti-inflammatories; anti-fungal medicines; pharmaceutical preparations for use in the treatment of infectious diseases, liver diseases and disorders, respiratory diseases and disorders, oncological diseases and disorders, hematological diseases and disorders and cardiovascular diseases and disorders
elejurn

General Information

Serial Number86558371
Word MarkELEJURN
Filing DateMonday, March 9, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 1, 2025
Registration Number5658682
Registration DateTuesday, January 22, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of HIV infection and hepatitis; antivirals; anti-inflammatories; anti-fungal medicines; pharmaceutical preparations for use in the treatment of infectious diseases, liver diseases and disorders, respiratory diseases and disorders, oncological diseases and disorders, hematological diseases and disorders and cardiovascular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 1, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCarrigtohill Co. Cork,
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Monday, April 6, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, March 12, 2015NEW APPLICATION ENTERED
Friday, March 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 1, 2015ASSIGNED TO EXAMINER
Monday, April 6, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 6, 2015EXAMINERS AMENDMENT E-MAILED
Monday, April 6, 2015EXAMINER'S AMENDMENT ENTERED
Monday, April 6, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 6, 2015LETTER OF SUSPENSION E-MAILED
Monday, April 6, 2015SUSPENSION LETTER WRITTEN
Friday, October 9, 2015ASSIGNED TO LIE
Tuesday, October 13, 2015SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, October 15, 2015SUSPENSION INQUIRY WRITTEN
Thursday, October 15, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, October 15, 2015INQUIRY TO SUSPENSION E-MAILED
Thursday, October 15, 2015SUSPENSION INQUIRY WRITTEN
Thursday, October 22, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 29, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 29, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 8, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 6, 2016SOU TEAS EXTENSION RECEIVED
Monday, June 6, 2016SOU EXTENSION 1 FILED
Monday, June 6, 2016SOU EXTENSION 1 GRANTED
Wednesday, June 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 22, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 22, 2016SOU EXTENSION 2 FILED
Thursday, December 22, 2016SOU EXTENSION 2 GRANTED
Saturday, December 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2017SOU EXTENSION 3 FILED
Wednesday, May 24, 2017SOU EXTENSION 3 GRANTED
Friday, May 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2017SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2017SOU EXTENSION 4 FILED
Thursday, November 30, 2017SOU EXTENSION 4 GRANTED
Saturday, December 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, June 5, 2018SOU EXTENSION 5 FILED
Friday, June 8, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 8, 2018SOU EXTENSION 5 GRANTED
Saturday, June 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 3, 2018TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, January 22, 2019REGISTERED-PRINCIPAL REGISTER
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 22, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 1, 2025CANCELLED SEC. 8 (6-YR)
Monday, December 3, 2018NOTICE OF ALLOWANCE CANCELLED
Thursday, December 13, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION

Related Keywords

elejurn diseases disorders pharmaceutical treatment anti preparations liver oncological cardiovascular hematological